Filtered By:
Management: Partnerships
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 1065 results found since Jan 2013.
School-Academic Partnerships in Support of Safe Return to Schools During the COVID-19 Pandemic
Safely returning underserved youth to school during the coronavirus disease 2019 (COVID-19) pandemic through diagnostic testing and health education is imperative to mitigate the ongoing negative impact of COVID-19 and reduce health inequalities in underserved communities. The Rapid Acceleration of Diagnostics-Underserved Populations program is a consortium of research projects across the United States funded by the National Institutes of Health to understand the factors associated with the disproportionate burden of the pandemic among underserved populations and to leverage mitigation strategies, including diagnostic test...
Source: PEDIATRICS - February 1, 2022 Category: Pediatrics Source Type: research
Coronavirus (COVID-19) Infection Survey headline results, UK: 26 January 2022, ONS
This study is jointly led by the ONS and the Department for Health and Social Care (DHSC) working with the University of Oxford and Lighthouse laboratory to collect and test samples.
Source: Current Awareness Service for Health (CASH) - January 26, 2022 Category: Consumer Health News Source Type: news
Boosters Are Effective Against Delta and Omicron Variants in Studies
Booster doses of COVID-19 vaccines increased protection against both the Delta and Omicron variants in three studies that looked at infections, hospital admissions and deaths in thousands of U.S. patients.
Third doses of messenger RNA vaccines made by Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE were at least 90% effective in preventing hospitalizations during both the Delta and Omicron periods, according to an analysis of hundreds of thousands of hospitalizations and clinic visits. The shots’ protection against COVID deaths was diminished after Omicron’s rise, but remained significant, accor...
Source: TIME: Health - January 21, 2022 Category: Consumer Health News Authors: Fiona Rutherford / Bloomberg Tags: Uncategorized COVID-19 News Desk wire Source Type: news
The World ’s Largest Vaccine Manufacturer Stumbled in 2021. Its CEO Bets He Can Still Help End COVID-19
Adar Poonawalla is no stranger to gambles. He owes his multibillion-dollar empire to a series of big bets that paid off handsomely. Cyrus Poonawalla, his father, made his own fortune on horses—and then multiplied it by making another bet in 1966: that he could make more money producing vaccines than he could on horse breeding and racing. He formed the Serum Institute of India (SII), which grew slowly for three decades, selling antivenoms and lifesaving vaccines for India.
When Adar, then just 21, joined the company in 2001, he persuaded his father to dramatically ramp up production—wagering that they could fill...
Source: TIME: Health - January 20, 2022 Category: Consumer Health News Authors: Abhishyant Kidangoor Tags: Uncategorized biztech2030 COVID-19 Davos feature Magazine overnight Special Project Source Type: news
Vaccination as a Condition of Deployment (VCOD) in England – UNISON Branch advice
Background
In late 2021, new regulations were agreed by parliament making it unlawful for an employer delivering Care Quality Commission (CQC) regulated activities, to deploy an unvaccinated worker in a face-to-face role from 1st April 2022. There are some limited medical exemptions within the regulations.
Vaccinated is defined as a “complete course of a Medicines and Healthcare products Regulatory Agency (MHRA) approved COVID-19 vaccine”. This does not currently include the booster jab.
The 3rd of February 2022 is the last date for workers to get their 1st dose to be fully vaccinated in time for when the regulations t...
Source: UNISON Health care news - January 17, 2022 Category: UK Health Authors: Cleopatra Parthenoglou Tags: Article Source Type: news
What is Biological E, the Indian company producing Corbevax?
The Hyderabad-based company says the vaccine will provide ‘sustainable access to low- and middle-income countries’The Indian biotechnology and biopharmaceutical company Biological E has produced the country ’s first locally developed Covid-19 vaccine in partnership with the Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine.The Hyderabad-based company has already produced 150m doses of the vaccine, called Corbevax, and will produce 100m doses each month beginning in February. It is expected that 1bn doses will be produced by the end of 2022 – just shy of India’s nearly 1.4-bi...
Source: Guardian Unlimited Science - January 15, 2022 Category: Science Authors: Erum Salam Tags: Vaccines and immunisation Coronavirus India World news Science Infectious diseases Source Type: news
Advancing child health and educational equity during the COVID-19 pandemic through science and advocacy
AbstractThe COVID-19 pandemic has underscored the changing role of scientists, clinicians, ethicists, and educators in advocacy as they rapidly translate their findings to inform practice and policy. Critical efforts have been directed towards understanding child well-being, especially with pandemic-related educational disruptions. While school closures were part of early widespread public health measures to curb the spread of COVID-19, they have not been without consequences for all children, and especially for children from disadvantaged backgrounds. In a recentIsr J Health Policy Res perspective, Paltiel and colleagues ...
Source: Israel Journal of Health Policy Research - January 7, 2022 Category: International Medicine & Public Health Source Type: research
Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States
NEW BRUNSWICK, N.J., January 6, 2022 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 vaccines in the United States (U.S.), showing that a single shot of the Johnson & Johnson COVID-19 vaccine resulted in long-lasting protection for up to six months against COVID-19 breakthrough infections, hospitalizations, and intensive care unit (ICU) admissions. The study was sponsored by the Janssen Pharmaceutical Companies of Johnson & Johnson and conducted in partnership with the Department of Science-Aetion, Inc, and the Division of ...
Source: Johnson and Johnson - January 6, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Coronavirus (COVID-19) Infection Survey, UK: 31 December 2021, ONS
This study is jointly led by the ONS and the Department for Health and Social Care (DHSC) working with the University of Oxford and Lighthouse laboratory to collect and test samples.
Source: Current Awareness Service for Health (CASH) - December 31, 2021 Category: Consumer Health News Source Type: news
UArizona Health Sciences Researchers to Study Long COVID as Part of National Collaborative
This study of post-acute sequelae of SARS-CoV-2, which is aimed at understanding the reasons for persistence of symptoms and organ involvement, assumes tremendous importance for us to devise new treatments and cures to address the long-term consequences of this pandemic, " said Dr.Sairam Parthasarathy, one of the project ' s multiple principal investigators.In addition to Parthasarathy, who is a professor of medicine and chief of the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine at the UArizona College of Medicine – Tucson and a BIO5 Institute member, principal investigators include Dr.Marilyn Glassber...
Source: The University of Arizona: Health - December 16, 2021 Category: Universities & Medical Training Authors: mittank Source Type: research
Coronavirus (COVID-19): Wedding and civil partnership ceremonies, receptions and celebrations, Department for Levelling Up, Housing and Communities and Cabinet Office (updated 16th December 2021)
Guidance for couples planning to get married or form a civil partnership in England, and venues hosting these events.
16 December 2021Information added about Plan B measures.
8 December 2021Information added on new measures introduced in response to the Omicron variant.
Source: Current Awareness Service for Health (CASH) - December 16, 2021 Category: Consumer Health News Source Type: news
Utilizing Academic-Community Partnerships With Nursing Students to Improve Hand Hygiene in Elementary Students to Reduce Transmission of COVID-19
This article describes a collaborative partnership initiative that expanded access to health promotion education in schools to increase knowledge about reducing the spread of infectious disease, such as COVID-19, while providing valuable clinical experiences for nursing students.
Source: Current Awareness Service for Health (CASH) - December 14, 2021 Category: Consumer Health News Source Type: news
NIDCR's Winter 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page.
NIDCR's Winter 2021 E-Newsletter
In this issue:
NIDCR News
Funding Opportunities & Related Notices
NIH/HHS News
Subscribe to NIDCR News
Science Advances
NIDCR News
NIDCR Major Announcement: Save the Date!
Mark your calendar for Tuesday, December 21, at 1pm for a major webcast announcement from NIDCR. Look for log-in instructions, coming in a separate NIDCR email next week.
Jennifer Webster-Cyriaque Joins NIDCR as Deputy Director
NIDCR welcomed Jennifer Webster-Cyriaqu...
Source: NIDCR Science News - December 8, 2021 Category: Dentistry Source Type: news
Coronavirus (COVID-19): Wedding and civil partnership ceremonies, receptions and celebrations, Department for Levelling Up, Housing and Communities and Cabinet Office (updated 8th December 2021)
Guidance for couples planning to get married or form a civil partnership in England, and venues hosting these events.
8 December 2021Information added on new measures introduced in response to the Omicron variant.
19 July 2021Updated to include guidance on changes from Step 4.
Source: Current Awareness Service for Health (CASH) - December 8, 2021 Category: Consumer Health News Source Type: news
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis
Purpose of review
Severe COVID-19 disease is often complicated by acute kidney injury (AKI), which may transition to chronic kidney disease (CKD). Better understanding of underlying mechanisms is important in advancing therapeutic approaches.
Recent findings
SARS-CoV-2-induced endothelial injury initiates platelet activation, platelet–neutrophil partnership and release of neutrophil extracellular traps. The resulting thromboinflammation causes ischemia–reperfusion (I/R) injury to end organs. Severe COVID-19 induces a lipid-mediator storm with massive increases in thromboxane A2 (TxA2) and PGD2, which promote...
Source: Current Opinion in Nephrology and Hypertension - December 6, 2021 Category: Urology & Nephrology Tags: NOVEL THERAPEUTIC APPROACHES IN NEPHROLOGY AND HYPERTENSION: Edited by Ekamol Tantisattamo, Ramy M. Hanna and Kamyar Kalantar-Zadeh Source Type: research
